Epithalon for sale is a phrase attached to two very different kinds of page. One is six factual fields with a paragraph of marketing wrapped around them. The other is the paragraph on its own, with the fields quietly left out, and the second kind is far more common.
Key takeaways
- Six fields carry all the information on a listing: form, quantity, batch number, storage, testing scope and the compliance line. Everything else on the page is a story anyone can write for free.
- The quantity field is where this compound is unusual. The published certificate reports a measured 9.64 mg in a vial labelled 10 mg, inside the stated tolerance and under the printed weight.
- That measurement moves the honest unit price from $2.50 per milligram to $2.59 at the discounted price, and it is a mark in the seller's favour for being printed at all.
- Testing scope beats a purity headline. FDA's concern with this substance is immunogenicity from aggregation and peptide-related impurities, which purity percentages do not measure.
- No field on any listing tells you the compound works. Epithalon is sold on ageing claims from a narrow research base, and the fields only establish what is in the vial.
Every field below is illustrated against one listing that fills all six in, so the example is on the page before the argument.
The vendor we point lifters to
Epithalon from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 23, 2026.
Epithalon for sale: the six fields, and what a blank one is hiding
| Field | What a real listing states | What the blank version means |
|---|---|---|
| Form | Lyophilised powder, sealed vial | Format left vague so capsules and solutions can share the price |
| Quantity | A milligram figure, ideally measured as well as printed | Nothing to divide the price by |
| Batch number | A lot printed on the vial and on the certificate | The certificate belongs to no particular vial |
| Storage | Conditions before and after opening | Nobody has thought about the supply chain |
| Testing scope | What the report for that lot actually covered | "Third-party tested" as a brand slogan |
| Compliance line | Research use, not for human consumption | A seller drifting into medical claims |
The fields are expensive to fill honestly and the story is free. That asymmetry is the whole method: read the fields, ignore the paragraph, and let the gaps do the work.
Form, and why a sealed vial is the only version with a checkable unit
Epithalon appears in the market in more than one format, and the price of one tells you nothing about the price of another.
The research-supplier version is lyophilised powder in a sealed vial, sold by mass. That is the format with a unit you can compute against, because the label carries a milligram figure and a certificate can report an assayed one. Consumer storefronts also sell capsules under a pineal peptide heading, usually with no total peptide content stated anywhere on the page, which means there is no denominator and no comparison to run.
Format also decides which questions matter. A sealed lyophilised powder is a dry, stable object with a defined moment when it stops being sterile, which is when someone opens it. A capsule taken orally raises a different set of questions that no listing in that corner of the market answers. Two different products, one search term, and only one of them has a price per milligram.
Quantity, and the field where this listing earns its keep
Here is where Epithalon listings differ from almost everything else this site has audited, and it is worth slowing down for.
The certificate behind the vial above covers batch 15-05260628, analysed by Kovera Labs, report KVR-2026-A36FF4, certified 05/23/2026. Its net content result is 9.64 mg. The label says 10 mg. The specification is 10 mg plus or minus 10 percent, so 9.64 mg is comfortably inside tolerance and nothing has failed.
It is also under the printed weight, and it changes the arithmetic. At $25.00 with the code, ten milligrams works out at $2.50 per milligram. Against the 9.64 mg actually measured, the same $25.00 is $2.59 per milligram. Both figures are true. The first one is on the marketing page and the second one is the one you paid.
Now consider what it takes to publish that. The cheap move for any vendor is to copy the label weight into the results column and let nobody check. Measuring the fill and printing a number that undercuts your own packaging is the behaviour of a company that treats certificates as records rather than as sales collateral. It is the opposite case to the neighbouring Russian peptide, where the same laboratory reported a lot running over its label rather than under, which we set out in Selank for sale. A supplier whose numbers land on both sides of its own label is reporting, not performing.
Which is why a listing that only quotes the label weight is a weaker listing than it looks. It is not lying. It is simply telling you what it printed rather than what it weighed.
The batch number, without which a certificate is decoration
A certificate with no lot number on it is a document about a company. A certificate with a lot number on it is a document about the vial in your hand.
That distinction eats most of the "third-party tested" claims in this market. Testing scope is a property of a batch, not of a brand, so the only version of the claim that means anything names a lot and can be matched against the label on the box that arrives. For this compound one certificate is published, covering batch 15-05260628, where the two other Russian peptides on this site carry two documents apiece from two laboratories.
The question to put to any seller is therefore not "do you test" but "which lot are you shipping me and what did its report cover". A seller who can answer will answer in about a line. A seller who cannot will change the subject to how long they have been in business.
Storage and testing scope, the two fields that answer FDA's actual concern
These two belong together because they are the fields that speak to the risk the regulator has actually named.
FDA's written concern is that compounded drugs containing epitalon may pose a risk of immunogenicity for certain routes of administration because of the potential for aggregation and peptide-related impurities, and that it has not identified safety-related information for the proposed route of administration. That is a manufacturing and handling statement, not a pharmacological one. Aggregation and impurities come from how material was made, dried, filled, shipped and stored.
So a purity headline answers a narrower question than most readers assume. Purity asks what fraction of the powder is the target molecule. It does not ask what else is in the vial, and bacterial endotoxin in particular persists long after the organisms that produced it are gone. The certificate above reports purity at 99.312% against a greater-than-98% specification, confirmed identity, an endotoxin screen against a 0.5 EU/mL acceptance limit reported as a pass, a microbial sterility screen returning no growth, and heavy metals including arsenic, cadmium and mercury screened. A 0.5 EU/mL limit is the kind of acceptance limit the bacterial endotoxins test in USP Chapter 85 is written around.
The storage field is the same argument extended past the warehouse door. A listing that states conditions before and after opening has thought about the part of the chain it does not control. A listing that says nothing has not, and the same failure mode on a different compound is documented in NAD+ for sale.
The compliance line, read correctly
The last field is the one readers skim, and it carries more information than any of the marketing above it.
A serious listing states that the material is sold for laboratory research use and is not for human consumption. That is not a formality and it is not a wink. It reflects the actual position: Epitalon has no FDA approval for any indication, and its bulk substance nomination was placed in category 2 under FDA's interim policies and then withdrawn, leaving it on no current category list and instead among the substances nominated but withdrawn. There is no compounded prescription version to compare against.
What makes the field diagnostic is what happens when a seller drifts off it. A storefront that starts describing outcomes, suggesting quantities or implying medical supervision has taken on a legal exposure no competent operator would accept, which tells you something about how the rest of the operation is run. Silence in this field is the professional answer.
What no field on the page can tell you
Fill all six fields perfectly and the listing still cannot answer the question a reader past forty actually has.
Epithalon is a synthetic tetrapeptide, four residues, Ala-Glu-Asp-Gly, listed by PubChem as Epitalon under CID 219042 with the formula C14H22N4O9 and a molecular weight of 390.35. It is marketed on telomere, telomerase and longevity claims that originate largely with Vladimir Khavinson's group in Russia, largely in Russian-language publications, and have not been replicated to Western standards. A PubMed search reflects that concentration, and ClinicalTrials.gov lists no registered study with it as an intervention.
Nothing in that is a training claim, and no honest seller pretends otherwise. What you are buying is an anti-ageing proposition with thin verification, in a vial whose contents are unusually well documented. Those are two separate facts and it is worth keeping them separate. If the thing that has actually changed is how long it now takes to recover between hard sessions, the levers with human evidence behind them are cheaper and duller, and we cover the most underrated one in sleep, cortisol and myostatin.
Frequently asked questions
What should an Epithalon listing state before I buy?
Form, quantity in milligrams, a batch number matching the vial, storage conditions before and after opening, what the certificate for that specific lot covered, and a research-use compliance line. If any of the six is missing, treat the absence as the answer to that question.
Are Epitalon and Epithalon vials for sale the same product?
Yes. FDA and PubChem write Epitalon, the peptide market mostly writes Epithalon, and both refer to the same tetrapeptide under PubChem CID 219042. Different spellings will return different search results, which is worth knowing when comparing prices, but there is only one molecule.
Why does a certificate report less than the label says?
Because the fill was weighed rather than assumed. On batch 15-05260628 the reported net content is 9.64 mg against a 10 mg label with a specification of 10 mg plus or minus 10 percent, so it is inside tolerance. It also means the honest unit price on that batch is $2.59 per milligram rather than $2.50.
Is a high purity number enough to trust a listing?
No, and it is the most over-weighted figure in this market. Purity states what fraction of the powder is the target molecule. It says nothing about bacterial endotoxin, which is measured separately against its own limit, and endotoxin is closer to the risk FDA has actually described for this substance.
Does a listing being research-use-only mean it is low quality?
The opposite, usually. That line reflects the real regulatory position, since there is no approved product and no current bulk category listing. A seller who omits it and talks about outcomes instead has taken on exposure that a careful operation would not, which tells you how carefully the rest is run.
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA
- Bulk Drug Substances Used in Compounding Under Section 503A, FDA
- Epitalon, PubChem CID 219042
- Certificate of analysis, Epithalon batch 15-05260628, Kovera Labs
- Published research on epitalon, PubMed
- Registered studies of Epitalon, ClinicalTrials.gov
This article is for educational purposes only and is not medical advice. Epithalon holds no FDA approval for any indication, has no US prescription route, and material sold by research suppliers is labelled for laboratory use only and not for human consumption. Claims about telomeres, telomerase and lifespan associated with this compound come largely from a single research lineage and have not been replicated to Western regulatory standards. Speak with a qualified healthcare professional before making any decision involving peptides, injections or unapproved compounds.